Rajeev Kallanthottathil

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Rajeev Kallanthottathil is an author at Alnylam Pharmaceuticals (United States) specializing in rna interference, gene-based complement therapy, and life sciences.

Publications per year

2013–2019

Publications

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis

Linda L. Kusner, Kristina Yucius, Manjistha Sengupta et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 53 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Aln-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition

Anna Borodovsky, Kristina Yucius, Andrew Sprague et al. · Blood · 2014 · 14 citations

Life Sciences, Immunology, Molecular Biology +14

Development Of RNAi Therapeutics Targeting The Complement Pathway

Anna Borodovsky, Kristina Yucius, Andrew Sprague et al. · Blood · 2013 · 12 citations

Life Sciences, Immunology, Molecular Biology +14

1–3 of 3